Xu X, Wang R, Su Q, Huang H, Zhou P, Luan J, et al
Despite the lack of rigorous clinical studies, case studies and independent experimental use have consistently yielded good results with few reports of adverse effects
While amyloid-beta plaques and neurofibrillary tangles are hallmark features, the fundamental problem is synaptic loss and neuronal death
These products have not been evaluated or approved by the Therapeutic Goods Administration (TGA), the Food and Drug Administration (FDA), or any other regulatory authority for human use
when present, symptoms typically reflect underlying conditions such as liver disease, haematological disorders, or renal impairment rather than the elevated vitamin itself